E.Seeley, S.Chimonas, and A.S.Kesselheim, “Can Outcomes-Based Pharmaceutical Contracts Reduce Drug Prices in the US?: A Mixed Methods Assessment, Journal of Law, Medicine & Ethics46, no. 4 (2018): 952-963.
2.
A.M.Duhig, S.Saha, S.Smith, S.Kaufman, and J.Hughes, “The Current Status of Outcomes-Based Contracting for Manufacturers and Payers: An AMCP Membership Survey,”Journal of Managed Care & Specialty Pharmacy24, no 5 (2018): 410-415; Duke Robert J. Margolis MD Center for Health Policy, Center for Health Policy, Overcoming Legal and Regulatory Hurdles to Value-Based Payment Arrangements for Medical Products, December 2017.
3.
Seeley, supra note 1.
4.
R.Dubois, M.Sherman, and R.Spurr, “More than Meets the Eye — Value-Based Contracts are More Prevalent than We Think,”paper presented at: AMCP Managed Care & Specialty Pharmacy Annual Meeting 2018, April 25, 2018, Boston, MA.
5.
Seeley, supra note 1.
6.
Seeley, supra note 1.
7.
Seeley, supra note 1.
8.
Seeley, supra note 1.
9.
T.Nazareth, J.J.Ko, R.Sasane, et al., “Outcomes-Based Contracting Experience: Research Findings from U.S. and European Stakeholders, Journal of Managed Care & Specialty Pharmacy23, no. 10 (2017):1018-1026.
